The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus

Author(s):
Kraaij, T.; Kamerling, S.W.A.; Rooij, E.N.M. de; Daele, P.L.A. van; Bredewold, O.W.; Bakker, J.A. (0000-0002-2918-7361); Bajema, I.M.; Scherer, H.U. (0000-0002-5700-5617); Toes, R.E.M. (0000-0002-9618-6414); Huizinga, T.J.W.; Rabelink, T.J.; Kooten, C. van (0000-0002-6257-0899); Teng, Y.K.O.
Published
2018
Publication type
Article / Letter to editor
Systemic lupus erythematosusLupus nephritisRefractory lupusRituximabBelimumabNeutrophil extracellular trapsAutoantibodyClinical trial
Date issued
2018-07-31
Language
English
Is part of
Journal of Autoimmunity (2018), Vol. 91, p. 45-54
hdl
1887/78833
doi
10.1016/j.jaut.2018.03.003